ADA Member Exclusive Recorded Webinar
This session explores the benefits and limitations of using automated insulin delivery (AID) systems during pregnancy for individuals with Type 1 diabetes, including impacts on glycemic outcomes, patient burdens, and system-specific constraints. The panel also reviews glucose targets across different AID systems, examines which user inputs most influence insulin delivery, and discusses clinical trial protocols designed to achieve stringent pregnancy glucose targets.